Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer Investigators propose to assess, retrospectively (from 1/7/2009) and prospectively (up to 31/12/2013,) the safety and tolerability profile (number of participants with adverse events) of s...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients Epithelial tumor cells can be detected in the bone marrow and/or the peripheral blood [disseminated and circulating tumor cells, (DTCs) and (CTCs) respectively] of otherwise metastases-fre...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer The purpose of this study is to evaluate whether the gemcitabine/vinorelbine combination versus the gemcitabine/docetaxel combination as first line treatment, offers a survival advantage i...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment Investigators propose to assess, retrospectively and prospectively the safety and tolerability profile (number of participants with adverse events) of standard chemotherapy and anti-angiog...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer Based on preclinical data, ZD1839 is considered a novel and promising therapeutic approach with potential application in the treatment of human breast cancer. Therefore it could be very im...

• Pays Greece
• Organes Aucun
• Spécialités Aucune

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) This trial will determine the maximum tolerated dose the recommended phase II dose and the efficacy of this combination in locally advanced or metastatic NSCLC patients

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer This is a retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on patients who have commenced ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment This study will evaluate the efficacy of Irinotecan,Capecitabine and Avastin combination in patients with no response to previous treatment with 5-Fluorouracil,Leucovorin,Eloxatin and Avas...

• Pays Greece
• Organes Aucun
• Spécialités Aucune

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC This trial will evaluate whether the sequential administration of Cisplatin/Vinorelbine/Bevacizumab followed by Docetaxel/Gemcitabine/Bevacizumab versus the Cisplatin/Docetaxel/Bevacizumab...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Efficacy Study of Vx001 Vaccine in NSCLC Patients Patients with stage IV or recurrent stage I-III NSCLC with documented disease control (objective response or stable disease) within 3 weeks after platinum based 1st line chemotherapy; only...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune